IMNM
Price
$8.72
Change
-$0.13 (-1.47%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
790.86M
15 days until earnings call
TCRX
Price
$1.81
Change
-$0.04 (-2.15%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
112.05M
63 days until earnings call
Ad is loading...

IMNM vs TCRX

Header iconIMNM vs TCRX Comparison
Open Charts IMNM vs TCRXBanner chart's image
Immunome
Price$8.72
Change-$0.13 (-1.47%)
Volume$5.19K
Capitalization790.86M
TScan Therapeutics
Price$1.81
Change-$0.04 (-2.15%)
Volume$1.1K
Capitalization112.05M
IMNM vs TCRX Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. TCRX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and TCRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (IMNM: $8.86 vs. TCRX: $1.86)
Brand notoriety: IMNM and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 78% vs. TCRX: 116%
Market capitalization -- IMNM: $790.86M vs. TCRX: $112.05M
IMNM [@Biotechnology] is valued at $790.86M. TCRX’s [@Biotechnology] market capitalization is $112.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 0 green, 5 red.
According to our system of comparison, TCRX is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 2 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 2 bullish, 5 bearish.
  • TCRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -0.89% price change this week, while TCRX (@Biotechnology) price change was +0.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.64%. For the same industry, the average monthly price growth was -8.11%, and the average quarterly price growth was -7.39%.

Reported Earning Dates

IMNM is expected to report earnings on May 08, 2025.

TCRX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+0.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($791M) has a higher market cap than TCRX($112M). IMNM YTD gains are higher at: -16.573 vs. TCRX (-38.816). TCRX has higher annual earnings (EBITDA): -102.91M vs. IMNM (-109.95M). TCRX has more cash in the bank: 271M vs. IMNM (240M). IMNM has less debt than TCRX: IMNM (2.72M) vs TCRX (90.4M). IMNM has higher revenues than TCRX: IMNM (10.1M) vs TCRX (9.36M).
IMNMTCRXIMNM / TCRX
Capitalization791M112M706%
EBITDA-109.95M-102.91M107%
Gain YTD-16.573-38.81643%
P/E RatioN/AN/A-
Revenue10.1M9.36M108%
Total Cash240M271M89%
Total Debt2.72M90.4M3%
TECHNICAL ANALYSIS
Technical Analysis
IMNMTCRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGEYX25.28N/A
N/A
George Putnam Balanced Y
MRAEX12.70N/A
N/A
Meridian Hedged Equity A
MAIIX17.04N/A
N/A
iShares MSCI EAFE Intl Idx Instl
POVSX27.74N/A
N/A
Putnam International Equity A
WISGX19.75N/A
N/A
Segall Bryant & Hamill Small Cap GrInstl

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-5.14%
KYMR - IMNM
50%
Loosely correlated
+0.40%
IDYA - IMNM
49%
Loosely correlated
-4.98%
CCCC - IMNM
48%
Loosely correlated
-8.90%
BEAM - IMNM
47%
Loosely correlated
-9.80%
AVIR - IMNM
47%
Loosely correlated
-2.01%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-6.06%
SYRE - TCRX
44%
Loosely correlated
-4.21%
CRVO - TCRX
42%
Loosely correlated
+2.71%
PRME - TCRX
42%
Loosely correlated
-13.33%
STRO - TCRX
41%
Loosely correlated
-9.33%
TSVT - TCRX
41%
Loosely correlated
+4.89%
More